HOFSETH BIOCARE ASA (HBC.OL) Forecast, Price Target & Analyst Ratings
OSL:HBC • NO0010598683
Current stock price
1.365 NOK
+0.02 (+1.49%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HOFSETH BIOCARE ASA (HBC.OL).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of NOK1.37 to mean target of N/A, Based on analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
%
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 194.874M 61.79% | 257.417M 32.09% | 256.34M -0.42% | |
| EBITDA YoY % growth | -87.102M 9.98% | -72.053M 17.28% | -72.934M -1.22% | |
| EBIT YoY % growth | -123.515M 2.87% | -111.834M 9.46% | -112.346M -0.46% | |
| Operating Margin | -63.38% | -43.44% | -43.83% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in NOK
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in NOK
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A